Prothena (NASDAQ:PRTA) Earns Buy Rating from HC Wainwright
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They ...
Bausch + Lomb (NYSE:BLCO) Price Target Cut to $17.00 by Analysts at Bank of America
Bausch + Lomb (NYSE:BLCO – Free Report) had its price target cut by Bank of America from $18.00 to $17.00 in a research ...